Search InvestCenter

Recent Quotes

My Watchlist

Top Indices

Latest News about Health & Science

Recent news which mentions Health & Science

...

9 10 11 12 13 14 15 16 17

...

Eli Lilly's weight loss drug slashes the risk of developing diabetes in long-term trial

August 20, 2024

Mpox outbreak: Here's how Asian nations have reacted to WHO emergency declaration

August 19, 2024

Here's why Walgreens and CVS retail pharmacies are struggling — and what they're doing to fix it

August 18, 2024

A new consumer privacy battle is underway as tech gadgets capture our brain waves

August 17, 2024

Epic Systems is pushing hospital customers to use new federal network for sharing medical records

August 16, 2024

Gilead Sciences alleges dangerous drug-counterfeiting operation at two NYC pharmacies in lawsuit

August 16, 2024

Mpox vaccine maker Bavarian Nordic seeks ‘critical’ EU approval for teens after WHO declares health emergency

August 16, 2024

What's next for the Biden administration's Medicare drug price negotiations

August 15, 2024

Health stocks jump as WHO declares mpox global health emergency

August 15, 2024

Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations

August 15, 2024

Healthy Returns: Eli Lilly gains momentum against Novo Nordisk in the weight loss drug market

August 14, 2024

Digital health company Ro launches GLP-1 insurance-coverage checker to help patients navigate costs

August 13, 2024

Eli Lilly blows past estimates, hikes guidance as Zepbound, Mounjaro sales soar

August 08, 2024

CVS slashes profit outlook on higher medical costs, says top Aetna executive will leave

August 07, 2024

Wegovy maker Novo Nordisk posts earnings miss, cuts operating profit outlook

August 07, 2024

Healthy Returns: What drugmakers are saying about final negotiated prices with Medicare

August 06, 2024

Eli Lilly's Zepbound and Mounjaro now available in U.S. after shortages, FDA says

August 02, 2024

Your health records are coming to new apps. Here's why

August 01, 2024

Eli Lilly's weight loss drug Zepbound cuts heart failure risks in late-stage study

August 01, 2024

Biogen beats expectations, hikes outlook as Alzheimer's drug Leqembi and other new products gain traction

August 01, 2024

Moderna beats estimates but slashes guidance on low EU sales, competitive U.S. vaccine market

August 01, 2024

23andMe CEO files proposal to take company private as stock craters

July 31, 2024

Healthy Returns: Here’s what GLP-1s are being tested for beyond weight loss, diabetes

July 31, 2024

Patients on Alzheimer's drug Leqembi see benefits over three years, Eisai study says

July 30, 2024

Neuralink rival Synchron lets patients control Apple Vision Pro with their thoughts

July 30, 2024

Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says

July 30, 2024

Pfizer beats earnings estimates, hikes full-year outlook as drugmaker cuts costs

July 30, 2024

Merck beats earnings expectations, raises sales outlook on strong demand for top drugs like Keytruda

July 30, 2024

Dexcom shares plunge more than 40%, head for worst day on record

July 26, 2024

European drug regulator rejects Alzheimer's treatment Leqembi from Biogen, Eisai

July 26, 2024

...

9 10 11 12 13 14 15 16 17

...

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.